E
Eileen M. Shore
Researcher at University of Pennsylvania
Publications - 201
Citations - 11651
Eileen M. Shore is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Fibrodysplasia ossificans progressiva & Heterotopic ossification. The author has an hindex of 55, co-authored 194 publications receiving 10587 citations. Previous affiliations of Eileen M. Shore include Seoul National University & Thomas Jefferson University.
Papers
More filters
Journal ArticleDOI
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva
Eileen M. Shore,Meiqi Xu,George J. Feldman,David A. Fenstermacher,Tae Joon Cho,In Ho Choi,J. Michael Connor,Patricia Delai,David L. Glaser,Martine Lemerrer,Rolf Morhart,John G. Rogers,Roger Smith,James T. Triffitt,J. Andoni Urtizberea,Michael Zasloff,Matthew A. Brown,Matthew A. Brown,Frederick S. Kaplan +18 more
TL;DR: Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.
Journal ArticleDOI
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
Frederick S. Kaplan,Meiqi Xu,Petra Seemann,J. Michael Connor,David L. Glaser,Liam Carroll,Patricia Delai,Elisabeth Fastnacht-Urban,Stephen J. Forman,Gabriele Gillessen-Kaesbach,Julie Hoover-Fong,Bernhard Köster,Richard M. Pauli,William Reardon,Syed Adeel Zaidi,Michael Zasloff,Rolf Morhart,Stefan Mundlos,Stefan Mundlos,Jay C. Groppe,Eileen M. Shore +20 more
TL;DR: Genotype‐phenotype correlation between some ACVR1 mutations and the age of onset of heterotopic ossification or on embryonic skeletal development is observed and protein structure homology modeling predicts that each of the amino acid substitutions activates the ACVR 1 protein to enhance receptor signaling.
Journal ArticleDOI
Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans Progressiva
Adam B. Shafritz,Eileen M. Shore,Francis H. Gannon,Michael Zasloff,Rebecca Taub,Maximilian Muenke,Frederick S. Kaplan +6 more
TL;DR: Overexpression of a potent bone-inducing morphogen (bone morphogenetic protein 4) in lymphocytes is associated with the disabling ectopic osteogenesis of fibrodysplasia ossificans progressiva.
Journal ArticleDOI
Fibrodysplasia ossificans progressiva
Frederick S. Kaplan,Martine Le Merrer,David L. Glaser,Robert J. Pignolo,Robert E. Goldsby,Joseph A. Kitterman,Jay C. Groppe,Eileen M. Shore +7 more
TL;DR: The recent discovery of overproduction of bone morphogenetic protein-4 in lesional cells and lymphocytic cells of affected patients provides a clue to both the underlying pathophysiology and potential therapy.
Journal ArticleDOI
Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells.
TL;DR: Examination of cell extracts for protein complexes containing the cell adhesion molecule uvomorulin indicates that separate complexes exist containing ankyrin and fodrin with either uvmorulin or Na+,K+-ATPase, and the presence of these proteins reflects direct molecular interactions which play roles in coordinating cell-cell contact and the assembly of the basal-lateral domain of the plasma membrane.